logo
Plus   Neg
Share
Email

Alexion Pharma Raises 2019 Outlook

Alexion Pharmaceuticals Inc. (ALXN) increased its revenues and earnings per share guidance for fiscal year 2019.

The company raised its fiscal year 2019 earnings per share outlook to a range of $8.58 to $8.78 from the prior estimation of $8.13 to $8.41 per share. It also increased its non-GAAP earnings per share guidance to a range of $10.25 to $10.40 from the previous outlook of $9.65 to $9.85 per share. Analysts polled by Thomson Reuters expect the company to report earnings of $9.94 per share for fiscal year 2019. Analysts' estimates typically exclude special items.

The company now projects total revenues for fiscal year 2019 to be $4.860 billion to $4.890 billion, compared to the prior outlook of $4.750 billion to $4.800 billion. Analysts expect revenues of $4.85 billion.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration has granted accelerated approval to Tazverik for the treatment of adults and pediatric patients aged 16 years and older with metastatic or locally advanced epithelioid sarcoma not eligible for complete resection. Epithelioid sarcoma is a rare sub-type of soft... STIHL recalls about 16,400 STIHL RE 90 pressure washers due to injury hazard. According to the company, the recalled pressure washer nozzle can disconnect from the spray wand when under pressure during use, posing an injury hazard. STIHL said it received seven reports of the nozzle detaching from... CVS Health Corp. launched 13 new HealthHUB locations in CVS Pharmacy stores across Philadelphia and South New Jersey. The healthcare company said it developed the HealthHUB store format to help people manage chronic conditions more conveniently and affordably. The store also features health and wellness products, clinical services and expertise.
Follow RTT
>